KKR to Acquire Integer Holdings in $4.3 Billion Cash Deal

In a move reflecting private equity's continued appetite for the healthcare sector, KKR has agreed to acquire Integer Holdings for approximately $4.3 billion. Under the terms of the deal, shareholders will receive $127.00 per share in cash as the company transitions to private ownership. This acquisition positions KKR as a major player in the medical device outsourcing market, where Integer Holdings serves as a critical development and manufacturing partner for large medical firms.

Following the announcement, financial institutions adjusted their outlooks based on the fixed acquisition price. Oppenheimer downgraded ITGR stock to 'Perform' from 'Outperform,' suggesting that the equity's upside is now capped near the $127.00 offer level. Per market reports, the deal has also drawn legal scrutiny, with Halper Sadeh LLC launching an investigation into the fairness of the transaction to determine if the board of directors secured maximum value for its shareholders.

As authoritative price data for the latest close is currently unavailable, market attention remains fixed on the stock's alignment with the acquisition price. Investors are also weighing broader financial conditions; according to the economic calendar, the Fed maintained interest rates at 3.75% on July 29, 2026, a factor that influences the financing landscape for large-scale private equity transactions like this one.